UniProt ID | EPM2A_HUMAN | |
---|---|---|
UniProt AC | O95278 | |
Protein Name | Laforin {ECO:0000303|PubMed:11001928} | |
Gene Name | EPM2A | |
Organism | Homo sapiens (Human). | |
Sequence Length | 331 | |
Subcellular Localization |
Cytoplasm . Under glycogenolytic conditions localizes to the nucleus. Isoform 1: Cytoplasm . Endoplasmic reticulum membrane Peripheral membrane protein Cytoplasmic side . Cell membrane . Colocalizes with glycogen synthase in punctate struct |
|
Protein Description | Plays an important role in preventing glycogen hyperphosphorylation and the formation of insoluble aggregates, via its activity as glycogen phosphatase, and by promoting the ubiquitination of proteins involved in glycogen metabolism via its interaction with the E3 ubiquitin ligase NHLRC1/malin. Shows strong phosphatase activity towards complex carbohydrates in vitro, avoiding glycogen hyperphosphorylation which is associated with reduced branching and formation of insoluble aggregates. [PubMed: 16901901] | |
Protein Sequence | MRFRFGVVVPPAVAGARPELLVVGSRPELGRWEPRGAVRLRPAGTAAGDGALALQEPGLWLGEVELAAEEAAQDGAEPGRVDTFWYKFLKREPGGELSWEGNGPHHDRCCTYNENNLVDGVYCLPIGHWIEATGHTNEMKHTTDFYFNIAGHQAMHYSRILPNIWLGSCPRQVEHVTIKLKHELGITAVMNFQTEWDIVQNSSGCNRYPEPMTPDTMIKLYREEGLAYIWMPTPDMSTEGRVQMLPQAVCLLHALLEKGHIVYVHCNAGVGRSTAAVCGWLQYVMGWNLRKVQYFLMAKRPAVYIDEEALARAQEDFFQKFGKVRSSVCSL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
25 | Phosphorylation | PELLVVGSRPELGRW CEEEEEECCCCCCCC | 32.81 | 11001928 | |
25 (in isoform 2) | Phosphorylation | - | 32.81 | 11001928 | |
25 (in isoform 4) | Phosphorylation | - | 32.81 | 11001928 | |
25 (in isoform 5) | Phosphorylation | - | 32.81 | 11001928 | |
59 (in isoform 7) | Phosphorylation | - | 5.09 | 24043423 | |
61 (in isoform 6) | Phosphorylation | - | 5.15 | - | |
62 (in isoform 7) | Phosphorylation | - | 25.89 | 24043423 | |
67 (in isoform 7) | Phosphorylation | - | 10.18 | 24043423 | |
74 (in isoform 7) | Phosphorylation | - | 54.25 | 24043423 | |
75 (in isoform 8) | Phosphorylation | - | 21.54 | 24043423 | |
78 (in isoform 8) | Phosphorylation | - | 35.04 | 24043423 | |
79 (in isoform 7) | Phosphorylation | - | 33.48 | 24043423 | |
83 (in isoform 7) | Phosphorylation | - | 17.14 | 24043423 | |
83 (in isoform 8) | Phosphorylation | - | 17.14 | 24043423 | |
84 (in isoform 7) | Phosphorylation | - | 6.09 | 24043423 | |
86 (in isoform 5) | Phosphorylation | - | 6.41 | 22817900 | |
86 (in isoform 4) | Phosphorylation | - | 6.41 | 22817900 | |
86 (in isoform 2) | Phosphorylation | - | 6.41 | 22817900 | |
86 | Phosphorylation | GRVDTFWYKFLKREP CCCCCHHHHHHCCCC | 6.41 | 22817900 | |
90 (in isoform 8) | Phosphorylation | - | 58.82 | 24043423 | |
95 (in isoform 8) | Phosphorylation | - | 43.30 | 24043423 | |
99 (in isoform 8) | Phosphorylation | - | 30.09 | 24043423 | |
100 (in isoform 8) | Phosphorylation | - | 39.13 | 24043423 | |
147 (in isoform 4) | Phosphorylation | - | 5.57 | - | |
150 (in isoform 7) | Phosphorylation | - | 15.54 | - | |
166 (in isoform 8) | Phosphorylation | - | 2.99 | - | |
213 (in isoform 2) | Phosphorylation | - | 28.82 | 24043423 | |
213 | Phosphorylation | NRYPEPMTPDTMIKL CCCCCCCCHHHHHHH | 28.82 | 24043423 | |
216 (in isoform 2) | Phosphorylation | - | 23.23 | 24043423 | |
216 | Phosphorylation | PEPMTPDTMIKLYRE CCCCCHHHHHHHHHH | 23.23 | 24043423 | |
221 (in isoform 2) | Phosphorylation | - | 15.81 | 24043423 | |
221 | Phosphorylation | PDTMIKLYREEGLAY HHHHHHHHHHCCCEE | 15.81 | 24043423 | |
228 (in isoform 2) | Phosphorylation | - | 10.52 | 24043423 | |
228 | Phosphorylation | YREEGLAYIWMPTPD HHHCCCEEEEECCCC | 10.52 | 24043423 | |
233 (in isoform 2) | Phosphorylation | - | 18.80 | 24043423 | |
233 | Phosphorylation | LAYIWMPTPDMSTEG CEEEEECCCCCCCCC | 18.80 | 24043423 | |
237 (in isoform 2) | Phosphorylation | - | 30.59 | 24043423 | |
237 | Phosphorylation | WMPTPDMSTEGRVQM EECCCCCCCCCHHCH | 30.59 | 24043423 | |
238 | Phosphorylation | MPTPDMSTEGRVQML ECCCCCCCCCHHCHH | 35.50 | 24043423 | |
238 (in isoform 2) | Phosphorylation | - | 35.50 | 24043423 | |
304 | Phosphorylation | MAKRPAVYIDEEALA HCCCCEEEECHHHHH | 12.54 | - | |
320 | Ubiquitination | AQEDFFQKFGKVRSS HHHHHHHHHCCHHHH | 51.43 | - | |
325 | Dimethylation | FQKFGKVRSSVCSL- HHHHCCHHHHHCCC- | 27.05 | - | |
325 | Methylation | FQKFGKVRSSVCSL- HHHHCCHHHHHCCC- | 27.05 | 24380735 |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
25 | S | Phosphorylation |
| 21728993 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of EPM2A_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
NFU1_HUMAN | NFU1 | physical | 12915448 | |
NHLC1_HUMAN | NHLRC1 | physical | 16115820 | |
GSK3B_HUMAN | GSK3B | physical | 16115820 | |
NHLC1_HUMAN | NHLRC1 | physical | 15930137 | |
NHLC1_HUMAN | NHLRC1 | physical | 18029386 | |
AAPK2_HUMAN | PRKAA2 | physical | 18029386 | |
AAKB2_HUMAN | PRKAB2 | physical | 18029386 | |
EPM2A_HUMAN | EPM2A | physical | 18617530 | |
NHLC1_HUMAN | NHLRC1 | physical | 18617530 | |
NHLC1_HUMAN | NHLRC1 | physical | 21505799 | |
PPR3D_HUMAN | PPP1R3D | physical | 23624058 | |
EPM2A_HUMAN | EPM2A | physical | 23922729 | |
NHLC1_HUMAN | NHLRC1 | physical | 23922729 | |
KPYM_HUMAN | PKM | physical | 26493215 | |
TOPRS_HUMAN | TOPORS | physical | 26493215 | |
COX5A_HUMAN | COX5A | physical | 26493215 | |
EPM2A_HUMAN | EPM2A | physical | 26493215 | |
PPR3C_HUMAN | PPP1R3C | physical | 26493215 | |
TDG_HUMAN | TDG | physical | 26493215 | |
PRS6A_HUMAN | PSMC3 | physical | 26493215 | |
HMGX4_HUMAN | HMGXB4 | physical | 26493215 | |
EI2BA_HUMAN | EIF2B1 | physical | 26493215 | |
NHLC1_HUMAN | NHLRC1 | physical | 26648032 | |
UBE2N_HUMAN | UBE2N | physical | 26546463 | |
NHLC1_HUMAN | NHLRC1 | physical | 26546463 | |
SQSTM_HUMAN | SQSTM1 | physical | 26546463 |
loading...
Phosphorylation | |
Reference | PubMed |
"Laforin, a dual-specificity phosphatase involved in Lafora disease,is phosphorylated at Ser25 by AMP-activated protein kinase."; Roma-Mateo C., Solaz-Fuster Mdel C., Gimeno-Alcaniz J.V.,Dukhande V.V., Donderis J., Worby C.A., Marina A., Criado O.,Koller A., Rodriguez De Cordoba S., Gentry M.S., Sanz P.; Biochem. J. 439:265-275(2011). Cited for: PHOSPHORYLATION AT SER-25 (ISOFORM 1), AND MUTAGENESIS OF SER-25;SER-168; THR-187 AND THR-194. |